Black Diamond Therapeutics Inc (BDTX)
2.54
+0.11
(+4.53%)
USD |
NASDAQ |
Nov 22, 16:00
2.55
+0.01
(+0.39%)
After-Hours: 20:00
Black Diamond Therapeutics Cash from Financing (Quarterly): -0.252M for Sept. 30, 2024
Cash from Financing (Quarterly) Chart
Historical Cash from Financing (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | -0.252M |
| June 30, 2024 | 21.38M |
| March 31, 2024 | 4.13M |
| December 31, 2023 | -0.046M |
| September 30, 2023 | 71.93M |
| June 30, 2023 | 0.00 |
| March 31, 2023 | 0.051M |
| December 31, 2022 | -0.028M |
| September 30, 2022 | 0.052M |
| June 30, 2022 | 0.00 |
| March 31, 2022 | 0.153M |
| December 31, 2021 | 0.00 |
| Date | Value |
|---|---|
| September 30, 2021 | 0.064M |
| June 30, 2021 | 0.184M |
| March 31, 2021 | 0.481M |
| December 31, 2020 | 0.83M |
| September 30, 2020 | 0.27M |
| June 30, 2020 | 0.00 |
| March 31, 2020 | 213.84M |
| December 31, 2019 | 83.50M |
| September 30, 2019 | 44.33M |
| June 30, 2019 | -0.07M |
| March 31, 2019 | 0.00 |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (Quarterly) Range, Past 5 Years
-0.252M
Minimum
Sep 2024
213.84M
Maximum
Mar 2020
19.83M
Average
0.1085M
Median
Cash from Financing (Quarterly) Benchmarks
| Vanda Pharmaceuticals Inc | -- |
| IDEAYA Biosciences Inc | 286.50M |
| NovaBay Pharmaceuticals Inc | 2.089M |
| Palatin Technologies Inc | -0.127M |
| iBio Inc | -0.162M |
Cash from Financing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -11.32M |
| Cash from Investing (Quarterly) | 2.193M |
| Free Cash Flow | -61.20M |
| Free Cash Flow Per Share (Quarterly) | -0.2004 |
| Free Cash Flow Yield | -44.79% |